Scott R Tobin's most recent trade in Champions Oncology Inc was a trade of 34,550 Option to purchase Common Stock done . Disclosure was reported to the exchange on Nov. 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | Scott R. Tobin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 34,550 | 34,550 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Scott R. Tobin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2023 | 28,600 | 28,600 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Scott R. Tobin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 21,200 | 21,200 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Scott R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.21 per share. | 12 Oct 2022 | 10,000 | 30,000 (0%) | 0% | 3.2 | 32,100 | Common Stock |
| Champions Oncology Inc | Scott R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2022 | 10,000 | 0 | - | - | Stock Options | |
| Champions Oncology Inc | Scott R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.59 per share. | 12 Oct 2021 | 10,000 | 20,000 (0%) | 0% | 1.6 | 15,900 | Common Stock |
| Champions Oncology Inc | Scott R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2021 | 10,000 | 0 | - | - | Stock Options | |
| Champions Oncology Inc | Scott R. Tobin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2020 | 10,000 | 10,000 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Scott R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2020 | 10,000 | 0 | - | - | Stock Options | |
| Champions Oncology Inc | Scott R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.46 per share. | 30 Oct 2020 | 10,000 | 10,000 (0%) | 0% | 5.5 | 54,600 | Common Stock |